Steffen Boettcher

24PUBLICATIONS
135CO-AUTHORS
Molecular targetsGene and molecular therapyHaematological tumoursMedical molecular engineering of nucleic acids and proteinsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Aug 17, 2026
Dual MYC and GSPT1 Protein Degrader for MYC-Driven Hematologic Malignancies.

|Jul 13, 2026
The novel hypomethylating agent NTX-301 reprograms epigenetic and Hippo signaling pathways and exhibits pre-clinical activity in venetoclax-resistant and TP53-mutant AML.

|Jan 06, 2026
Bone marrow failure, somatic rescue by p53 inactivation, and enhanced leukemogenesis in germ line ERCC6L2 disease.

Roman R Schimmer, Nancy Klemm, Jonas Fullin

|Dec 17, 2025
The pathogenesis of therapy-related myeloid neoplasms from TP53-mutant clonal hematopoiesis.

Jonas Fullin, Ebru Topçu, Karolina A Zielińska

|Jul 03, 2025
Restoring p53 wild-type conformation in TP53-Y220C-mutant acute myeloid leukemia.

Bing Z Carter, Po Yee Mak, Edward Ayoub

|May 21, 2025
Correction: Targeting of epigenetic co-dependencies enhances anti-AML efficacy of Menin inhibitor in AML with MLL1-r or mutant NPM1.

Warren Fiskus, Christopher P Mill, Christine Birdwell

Pageof 4

Frequent Collaborators

8 joint publications

Markus G Manz

8 joint publications

Benjamin L Ebert

7 joint publications

Lauren B Ostermann

7 joint publications

Michael Andreeff